0001354488-15-005385.txt : 20151207
0001354488-15-005385.hdr.sgml : 20151207
20151207074152
ACCESSION NUMBER: 0001354488-15-005385
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151204
FILED AS OF DATE: 20151207
DATE AS OF CHANGE: 20151207
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Midatech Pharma US Inc.
CENTRAL INDEX KEY: 0000919745
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043216862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8601 SIX FORKS ROAD SUITE 160
CITY: RALEIGH
STATE: NC
ZIP: 27615
BUSINESS PHONE: (816) 914-7027
MAIL ADDRESS:
STREET 1: 8601 SIX FORKS ROAD SUITE 160
CITY: RALEIGH
STATE: NC
ZIP: 27615
FORMER COMPANY:
FORMER CONFORMED NAME: DARA BioSciences, Inc.
DATE OF NAME CHANGE: 20080225
FORMER COMPANY:
FORMER CONFORMED NAME: DARA BIOSCIENCES INC
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: POINT THERAPEUTICS INC
DATE OF NAME CHANGE: 20020328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tousley David L.
CENTRAL INDEX KEY: 0001436567
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23776
FILM NUMBER: 151271267
MAIL ADDRESS:
STREET 1: 14610 PAWNEE LANE
CITY: LEAWOOD
STATE: KS
ZIP: 66224
4
1
issuerdirect_section16.xml
PRIMARY DOCUMENT
X0306
4
2015-12-04
1
0000919745
Midatech Pharma US Inc.
DARA
0001436567
Tousley David L.
8601 SIX FORKS ROAD
SUITE 160
RALEIGH
NC
27615
1
CFO
Stock Option
4.90
2015-12-04
2015-12-04
4
D
0
35000
D
2015-12-04
2023-03-01
Common Stock
35000
0
D
Stock Option
2.90
2015-12-04
2015-12-04
4
D
0
40000
D
2015-12-04
2024-03-04
Common Stock
40000
0
D
Stock Option
.79
2015-12-04
2015-12-04
4
D
0
97000
D
2015-12-04
2025-02-09
Common Stock
97000
0
D
Stock Option
.69
2015-12-04
2015-12-04
4
D
0
35000
D
2019-05-19
2025-05-19
Common Stock
35000
0
D
In connection with the closing of the Agreement and Plan of Merger among DARA BioSciences, Inc. (DARA), Midatech Pharma PLC (Midatech) and certain other parties thereto, these options were assumed by Midatech and replaced with options to purchase 0.136 Midatech American Depository Receipts (Midatech ADRs) for each DARA option held, at an exercise price equal to the exercise price of the applicable DARA option divided by 0.136. Each Midatech ADR represents two Midatech ordinary shares.
/s/ David L. Tousley
2015-12-07